Cure My Disease

Don't miss your cure!

 Log in / Sign up

Glow-in-the-Dark dye could speed up prostate cancer detection

NCT ID NCT07690462

Not yet recruiting Diagnosis Sponsor: Xiangya Hospital of Central South University Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study tests a new infrared fluorescence staining technique that could help doctors diagnose prostate cancer faster during a biopsy. The method is compared to the standard frozen section analysis and the gold-standard paraffin section. If successful, it may offer a quicker, more accurate way to identify cancer cells in prostate tissue samples.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
infrared fluorescence rapid staining technique
What this could lead to
If accurate, this technique could provide faster, more reliable prostate cancer diagnosis during biopsy, potentially reducing the need for repeat procedures.
What could go wrong
This is a validation study with 120 participants, so results may not generalize. The new method might not match the accuracy of standard pathology, and technical issues could limit its use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Xiangya Hospital Central South University

    Changsha, Hunan, 410008, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.